EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-21.28%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$380M
AUM Growth
+$380M
(-23%)
Cap. Flow
-$17.6M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
66.51%
Holding
81
New
10
Increased
16
Reduced
22
Closed
22
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$37.5M |
| 2 |
TG Therapeutics
TGTX
|
$16.6M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$15.8M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$11.7M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$10.4M |
Top Sells
| 1 |
GSK
GSK
|
$19.9M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$18.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$16M |
| 4 |
The Ensign Group
ENSG
|
$12M |
| 5 |
Sanofi
SNY
|
$11M |
Sector Composition
| 1 | Healthcare | 89.32% |
| 2 | Communication Services | 2.19% |
| 3 | Financials | 0.12% |
| 4 | Industrials | 0% |
| 5 | Real Estate | 0% |
